S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

ACHV Achieve Life Sciences Inc

4.735

0.045 (0.96%)

May 03 2024 - Closed

Delayed by 15 minutes

IAC/InterActiveCorp, Golden Ocean Group among premarket losers' pack

To read the full story on Seeking Alpha, click here.

Achieve Life Sciences (NASDAQ:ACHV)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Achieve Life Sciences Charts.

Achieve Life Sciences (NASDAQ:ACHV)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Achieve Life Sciences Charts.

Achieve Life Sciences Inc News

Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024
Thursday 25 April 2024 (1 week ago) • GlobeNewswire Inc.

Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference
Thursday 11 April 2024 (3 weeks ago) • GlobeNewswire Inc.

Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update
Thursday 28 March 2024 (1 month ago) • GlobeNewswire Inc.

Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting
Wednesday 20 March 2024 (1 month ago) • GlobeNewswire Inc.

Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024
Thursday 14 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)

Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission
Thursday 29 February 2024 (2 months ago) • GlobeNewswire Inc.

Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement
Thursday 29 February 2024 (2 months ago) • GlobeNewswire Inc.

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Tuesday 27 February 2024 (2 months ago) • Edgar (US Regulatory)

More Achieve Life Sciences Inc News Articles

Bell Buckle (PK)

Umbra Applied Technologies (PK)

Marketing Worldwide (PK)

Code Green Apparel (PK)

Moon Equity (PK)

Cann American (CE)

AMC Entertainment

Digital Brand Media and ... (PK)

Intergrated Cannabis Sol... (PK)

1812 Brewing (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions